Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype

Mahmooda Mirza1, Steven Marston, Ruth Willott

  • 1National Heart and Lung Institute, Imperial College London, London SW3 6LY, United Kingdom.

Insights

Inherited dilated cardiomyopathy (DCM) mutations in cardiac muscle proteins reduce heart contractility. This contrasts with hypertrophic cardiomyopathy mutations, suggesting distinct molecular mechanisms drive these heart conditions.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Muscle Physiology

Background:

  • Dilated cardiomyopathy (DCM) is a primary cause of heart failure, often stemming from inherited genetic mutations.
  • Mutations in cardiac troponin T, troponin C, and alpha-tropomyosin genes are linked to inherited DCM, but can also cause hypertrophic cardiomyopathy with different mutations.
  • Conflicting findings in prior studies necessitate a comprehensive analysis of DCM-associated mutations.

Purpose of the Study:

  • To elucidate how specific genetic mutations lead to dilated cardiomyopathy.
  • To investigate the impact of known DCM-causing mutations on cardiac contractile function.
  • To compare the functional effects of DCM mutations with those causing hypertrophic cardiomyopathy.

Main Methods:

  • Reconstitution of cardiac thin filaments with wild-type and mutant proteins (troponin T, troponin C, alpha-tropomyosin) at a 1:1 ratio.
  • In vitro assays including ATPase activity and motility assays to assess Ca(2+) sensitivity and activation.
  • Inclusion of skinned cardiac trabeculae experiments with specific troponin T mutants to evaluate force generation.

Main Results:

  • All thin filaments with DCM mutations exhibited reduced Ca(2+) sensitivity in ATPase and motility assays.
  • Most mutants showed decreased maximum Ca(2+) activation, with one exception (alpha-tropomyosin).
  • Incorporation of two troponin T mutants into cardiac trabeculae reduced Ca(2+) sensitivity of force generation.

Conclusions:

  • Diverse thin filament DCM mutations consistently impair myofibrillar function, leading to decreased contractility.
  • This depressive effect on contractility is mechanistically opposite to that observed in hypertrophic cardiomyopathy-causing thin filament mutations.
  • Reduced cardiac contractility due to these mutations may initiate pathological pathways culminating in the clinical presentation of DCM.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
The Sarcomere01:08

The Sarcomere

A sarcomere is a microscopic segment repeating in a myofibril. The sarcomere fundamentally consists of two main myofilaments: thick filaments called myosin and thin filaments called actin. These filaments interact by sliding past each other in response to stimulus. In addition to myosin and actin, several other proteins, such as tropomyosin, troponin, titin, nebulin, myomesin, α-actinin, and dystrophin, play crucial roles in regulating, structuring, and functioning of the sarcomere.
Each myosin...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Actin Polymerization and Cell Motility01:13

Actin Polymerization and Cell Motility

Actin is a family of globular proteins that are highly abundant in eukaryotic cells. It makes up approximately 1-5% of total cell protein concentration. Actin monomers polymerize to form a complex network of polarized filaments, the actin cytoskeleton, that plays a crucial role in many cellular processes, including cell motility, division, endocytosis, and metastasis of cancer cells.
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.